Skip to main content

Advertisement

Log in

Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL

  • Original article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the feasibility of using 99mTc-glutamate peptide-estradiol in functional imaging of estrogen receptor-positive [ER(+)] diseases.

Methods

3-Aminoethyl estradiol (EDL) was conjugated to glutamate peptide (GAP) to yield GAP-EDL. Cellular uptake studies of 99mTc-GAP-EDL were conducted in ER(+) cell lines (MCF-7, 13762 and T47D). To demonstrate whether GAP-EDL increases MAP kinase activation, Western blot analysis of GAP-EDL was performed in 13762 cells. Biodistribution was conducted in nine rats with 13762 breast tumors at 0.5–4 h. Each rat was administered 99mTc-GAP-EDL. Two animal models (rats and rabbits) were created to ascertain whether tumor uptake of 99mTc-GAP-EDL was via an ER-mediated process. In the tumor model, breast tumor-bearing rats were pretreated with diethylstilbestrol (DES) 1 h prior to receiving 99mTc-GAP-EDL. In the endometriosis model, part of the rabbit uterine tissue was dissected and grafted to the peritoneal wall. The rabbit was administered with 99mTc-GAP-EDL.

Results

There was a 10–40% reduction in uptake of 99mTc-GAP-EDL in cells treated with DES or tamoxifen compared with untreated cells. Western blot analysis showed an ERK1/2 phosphorylation process with GAP-EDL. Biodistribution studies showed that tumor uptake and tumor-to-muscle count density ratio in 99mTc-GAP-EDL groups were significantly higher than those in 99mTc-GAP groups at 4 h. Among 99mTc-GAP-EDL groups, region of interest analysis of images showed that tumor-to muscle ratios were decreased in blocking groups. In the endometriosis model, the grafted uterine tissue could be visualized by 99mTc-GAP-EDL.

Conclusion

Cellular or tumor uptake of 99mTc-GAP-EDL occurs via an ER-mediated process. 99mTc-GAP-EDL is a useful agent for imaging functional ER(+) disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987;5:55–61.

    PubMed  CAS  Google Scholar 

  2. Rose C, Thorpe SM, Andersen KW, Pedersen BV, Mouridsen HT, Blichert-Toft M, et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985;1:16–9.

    Article  PubMed  CAS  Google Scholar 

  3. Bertelsen CA, Giuliano AE, Kern DH, Mann BD, Roe DJ, Morton DL. Breast cancers: estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response. J Surg Res 1984;37:257–63.

    Article  PubMed  CAS  Google Scholar 

  4. van Netten JP, Armstrong JB, Carlyle SS, Goodchild NL, Thornton IG, Brigden ML, et al. Estrogen receptor distribution in the peripheral, intermediate and central regions of breast cancers. Eur J Cancer Clin Oncol 1988;24:1885–9.

    Article  PubMed  Google Scholar 

  5. Inoue T, Kim EE, Wallace S, Yang DJ, Wong FCL, Bassa P, et al. Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study. Cancer Biotherapy Radiopharm 1996;11:235–45.

    Article  CAS  Google Scholar 

  6. Yang DJ, Li C, Kuang L-R, Tansey W, Cherif A, Price J, et al. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues. Life Sci 1994;55:53–67.

    Article  PubMed  CAS  Google Scholar 

  7. Inoue T, Kim EE, Wallace S, Yang DJ, Wong FC, Bassa P, et al. Preliminary study of cardiac accumulation of [18F]fluorotamoxifen in patients with breast cancer. Clin Imaging 1997;21:332–6.

    Article  PubMed  CAS  Google Scholar 

  8. Mankoff DA, Peterson LM, Tewson TJ, Link JM, Gralow JR, Graham MM, et al. [18F]fluoroestradiol radiation dosimetry in human PET studies. J Nucl Med 2001;42(4):679–84.

    PubMed  CAS  Google Scholar 

  9. Aliaga A, Rousseau JA, Ouellette R, Cadorette J, van Lier JE, Lecomte R, et al. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol 2004;31:761–70.

    Article  PubMed  CAS  Google Scholar 

  10. Hudelist G, Keckstein J, Czerwenka K, Lass H, Walter I, Auer M, et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril 2005;84 Suppl 2:1249–56.

    Article  PubMed  CAS  Google Scholar 

  11. Tanahatoe SJ, Lambalk CB, Hompes PG. The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study. Hum Reprod 2005;20:3225–30.

    Article  PubMed  CAS  Google Scholar 

  12. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 1998;22:295–9.

    Article  PubMed  CAS  Google Scholar 

  13. Raynal C, Delmas PD, Chenu C. Bone sialoprotein stimulates in vitro bone resorption. Endocrinology 1996;137:2347–54.

    Article  PubMed  CAS  Google Scholar 

  14. Nouhi Z, Chughtai N, Hartley S, Cocolakis E, Lebrun JJ, Ali S. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res 2006;66:1824–32.

    Article  PubMed  CAS  Google Scholar 

  15. Delpassand ES, Yang DJ, Wallace S, Cherif A, Quadri SM, Joubert A, et al. Synthesis, biodistribution and estrogen receptor scintigraphy of an 111In-DTPA-tamoxifen analogue. J Pharm Sci 1996;85:553–9.

    Article  PubMed  CAS  Google Scholar 

  16. Borras C, Gambini J, Gomez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 2005;4:113–8.

    Article  PubMed  CAS  Google Scholar 

  17. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292–300.

    PubMed  CAS  Google Scholar 

  18. Watson CS, Norfleet AM, Pappas TC, Gametchu B. Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-alpha. Steroids 1999;64:5–13.

    Article  PubMed  CAS  Google Scholar 

  19. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci U S A 2000;97:3602–7.

    Article  PubMed  CAS  Google Scholar 

  20. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol 2002;16:116–27.

    Article  PubMed  CAS  Google Scholar 

  21. Dunselman GA, Willebrand D, Land JA, Bouckaert PX, Evers JL. A rabbit model of endometriosis. Gynecol Obstet Invest 1989;27:29–33.

    Article  PubMed  CAS  Google Scholar 

  22. Classe JM, Fiche M, Rousseau C, Sagan C, Dravet F, Pioud R, et al. Prospective comparison of 3 gamma-probes for sentinel lymph node detection in 200 breast cancer patients. J Nucl Med 2005;46:395–9.

    PubMed  Google Scholar 

  23. Krynyckyi BR, Chun H, Kim HH, Eskandar Y, Kim CK, Machac J. Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy. J Nucl Med 2003;44:1387–93.

    PubMed  Google Scholar 

  24. Fleming JS, Wilkinson J, Oliver RM, Ackery DM, Blake GM, Waller DG. Comparison of radionuclide estimation of glomerular filtration rate using technetium 99m diethylenetriaminepentaacetic acid and chromium 51 ethylenediaminetetraacetic acid. Eur J Nucl Med 1991;18:391–5.

    Article  PubMed  CAS  Google Scholar 

  25. Carlsen O. The gamma camera as an absolute measurement device: determination of glomerular filtration rate in99mTc-DTPA renography using a dual head gamma camera. Nucl Med Commun 2004;25:1021–9.

    Article  PubMed  Google Scholar 

  26. Verhaeren EH, Dreessen MJ, Lemli JA. Influence of 1,8-dihydroxyanthraquinone and loperamide on the paracellular permeability across colonic mucosa. J Pharm Pharmacol 1981;33:526–8.

    PubMed  CAS  Google Scholar 

  27. Panwar P, Iznaga-Escobar N, Mishra P, Srivastava V, Sharma RK, Chandra R, et al. Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy. Cancer Biol Ther 2005;4:854–60.

    Article  CAS  Google Scholar 

  28. Frennby B, Sterner G. Contrast media as markers of GFR. Eur Radiol 2002;12:475–84.

    Article  PubMed  Google Scholar 

  29. Piepsz A. Radionuclide studies in paediatric nephro-urology. Eur J Radiol 2002;43:146–53.

    Article  PubMed  Google Scholar 

  30. Reiman RE, Benua RS, Gelbard AS, Allen JC, Vomero JJ, Laughlin JS. Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication. J Nucl Med 1982;23:682–7.

    PubMed  CAS  Google Scholar 

  31. Gelbard AS, Benua RS, Laughlin JS, Rosen G, Reiman RE, McDonald JM. Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. J Nucl Med 1979;20:782–4.

    PubMed  CAS  Google Scholar 

  32. Sordillo PP, Reiman RE, Gelbard AS, Benua RS, Magill GB, Laughlin JS. Scanning withL-(13 N) glutamate: assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma. Am J Clin Oncol 1982;5:285–9.

    PubMed  CAS  Google Scholar 

  33. Jordan VC. Designer estrogens. Sci Am 1998;279:60–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Eloise Daigle for her secretarial support. This work was supported in part by MDACC sponsored research grant (LS2005-00012824PL, Mr. Kazuhiko Sugiura, Methods, Ltd., Tokyo, Japan) and the United States Army Department of Defense Breast Cancer Research Grant Concept Award (DoD BCRP W81XWH-04-1-06-24). The animal research is supported by M.D. Anderson Cancer Center (CORE) Grant NIH CA-16672.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David J. Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, N., Yang, D.J., Kohanim, S. et al. Targeted functional imaging of estrogen receptors with 99mTc-GAP-EDL. Eur J Nucl Med Mol Imaging 34, 354–362 (2007). https://doi.org/10.1007/s00259-006-0191-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-0191-6

Keywords

Navigation